Skip to content

Docs (opens in a new tab)Pricing Research Benchmark

Sign in Sign up

L

LRMR

Larimar Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$3.83

+0.00%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsAnalysis

Research · Sep 3, 2026

LRMR: FY25 Deep Dive

Larimar Therapeutics FY25 at $0M. NI $-166M; EPS $-2.27.

The idea engine
for fundamental investors.

Product

Ask drillr Watchlist

Resources

Research Methodology Benchmark Docs (opens in a new tab)

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Pricing Privacy Terms© 2026 LIL GREBE INC.